Keith Michael Gottesdiener, CEO & President at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 20,580 shares at $30.04 ($619K) on 2019-03-15, disclosed to the SEC on 2019-03-19.
Open-market sale of $619k RYTM by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.04 | 7,961 | $239K | 38.6% |
| 2 | $30.04 | 7,961 | $239K | 38.6% |
| 3 | $30.27 | 2,329 | $70K | 11.4% |
| 4 | $30.27 | 2,329 | $70K | 11.4% |
| Total | $30.09 avg | 20,580 | $619K | 100% |
| Filing → |
| RYTM | SELL | 2019-02-20 | $748K | — | Filing → |
| RYTM | SELL | 2019-02-15 | $118K | — | Filing → |
| RYTM | SELL | 2019-01-24 | $945K | — | Filing → |